吉林性功能障碍要怎么治(吉林最专业的男科医院在哪里) (今日更新中)

When you mix sugar, spice, and everything nice, you get "The Powerpuff Girls." But this time, it's a live-action version.According to Variety, Bubbles, Blossom, and Buttercup are getting back together for a remake. The premise of The CW show, which is still in development, will be about the girls in their 20s and are resentful because they lost their childhood because they were fighting crime, Variety stated.According to Vulture, Diablo Cody and Heather Regnier will write and executive produce the show.The original animated series aired from 1998 to 2005 on Cartoon Network and was created by Craig McCracken, Deadline reported.Variety reported that there was also a movie in 2002, and Cartoon Network rebooted the animated series in 2016.No word yet on when the live-action series will debut. 807

While experts are encouraged by early vaccine data, many still say there is a way to go before life returns to normalcy."Operation Warp Speed," is a Trump administration effort to develop and deliver a safe and effective COVID-19 in the coming months. The administration's goal is to make initial doses available by January 2021.The vaccine will initially be rationed while drugmakers produce more doses. Healthcare workers, people in nursing homes, first responders and those with high-risk health conditions will likely be the first people eligible to receive the vaccine. According to Dr. Anthony Fauci, the director of the National Insitute for Allergies and Infectious Diseases, the rest of the general population won't be able to receive the vaccine until later in 2021.Pfizer and Moderna have both announced that their vaccines are on track for potential emergency authorization from the Food and Drug Administration. But there are several other candidates that could also get approval soon — and could potentially overtake the market.Both Pfizer's and Moderna's vaccine candidates require two shots, which need to be taken 28 days apart. But health experts believe that if a single-dose vaccine gets approval, it could quickly become the standard for worldwide vaccination."So, if you can get a vaccine out there that actually requires only one dose, it could quickly overtake the market," said Dr. Marcus Schabacker the President & CEO, of Emergency Care Research Institute.Health experts are also encouraged that there are several vaccine candidates in the final stages of testing — they believe that more potential vaccines reduce safety risks."We have a lot of people in the world. We need to vaccinate in different countries under different criteria, and you always run the risk that there's something in the Pfizer vaccine that someone's allergic to that isn't in the Madonna vaccine," said Dr. Jill Roberts, an associated professor as USF Health.One question that hasn't yet been answered is how the vaccines will stand up to the newly infected."So if you're turning positive today, we know you are exposed to somebody that had COVID, and we vaccinate you today — will that actually prevent you from developing severe disease?" Roberts said.Merck is another U.S. based pharmaceutical company that is working on a single-dose COVID-19 vaccine. That vaccine is currently in early testing overseas. 2422

When you're facing a medical emergency, you trust your life to the doctors at in the emergency room. Those doctors sometimes have just seconds to make life or death decisions. Four in Your Corner is giving you an inside look as to what it's like to be an ER doctor."I love the pace of things and it takes a certain person to be an ER doctor," Dr. Keith Burley, who works in Cape Coral Hospital's emergency room, said/ "Emergency medicine is a true team sport. It takes the whole department to really resuscitate someone who is very sick.""Say someone comes in in cardiac arrest. They come in right through our trauma bay doors. They're dropped into one of our resuscitation rooms. Our team organizes very quickly. Everyone knows their jobs," Dr. Burley said.\In cases like this, techs will be running IVs; nurses will be hooking up defibrillation pads. Pharmacists will be running drugs. Staff will be trying to find out a patient's name. Dr. Burley said it's all about balancing quickness with efficiency while making sure patients are safe during triage."It's very important we triage effectively, making sure we point out and pick up the really sick people early on so we dedicate most of our resources to those sick people," Dr. Burley said. "We do need to triage because we have limited resources we need to effectively implement."Dr. Burley said when he sees a patient, he's trained to think worst case-scenario first."So someone coming in with a headache, we think, could this be a stroke? Could this be a subarachnoid hemorrhage? Could this be something else going on? Before we think it's just a headache," he said.Dr. Burley has known he's wanted to be a doctor since he was four years old after he was in a life-changing, dangerous situation."Like a good Canadian, I was tobogganing down a hill. We were going down the hill and my brother bailed. We continued to go down the hill and I hit a tree with my head," he said.He had a fractured skull and lost hearing in his left ear."I was seen by ER doctors, trauma doctors, a pediatric neurologist, had multiple MRIs," he said. "From that point on, as a young child, I always wanted to be a doctor."He said one of his most bizarre cases was just hours before Hurricane Irma hit. A dog was brought into the ER with it's eye hanging out."I'm not a veterinarian and I don't pretend to be one. I have a dog but it's a little out of my realm," Dr. Burley said. "We placed a pressured dressing and one of the staff members was able to call around to get a vet to see that dog just before the storm."For that dog and family, it was a happy ending, but Dr. Burley said the hardest part about emergency medicine are the days he deals with death and dying."It takes a certain person to deal with death and dying every day and then come back. It's a resiliency characteristic that all the ER staff have," Dr. Burley said.Whether their patients survive or not, the doctors have to learn to compartmentalize -- going from patient to patient until the end of their eight to 10 hour shift."We'll see a pediatric drowning, and then the next case we'll see someone with an eyeball injury, or someone with a simple laceration, and we have to give that patient the same amount of attention we gave the other patient and reset," he said."It's a privilege to be in a discipline where you get to see someone on their worst day of their entire life, and if you can make that a little better, you've done your job," he said.Dr. Burley said to unwind, he spends a lot of time at the beach and kite surfing. 3562

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

When talking about veteran mental health, much of the conversation is centered on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). While both are widespread and debilitating, the mental health-related challenges veterans face go beyond these conditions.Dependable, courageous, and in peak physical shape, Theresa Larson chased perfection when joining the Marine Corps.“I wanted to be the exemplary Marine," said Larson. "To the T. What does a good Marine officer do? I had to do that.”A stellar student and Division 1 college athlete, she had been training for a challenge like this her entire life. With two older brothers in the military, Larson was well aware of the unique challenges she'd face as a female leader. “You have to be really fit and healthy. You have to be fitter than them. They're going to look at you physically and see how you perform," said Larson.Leader of a platoon, Larson was responsible for more than 50 Marines, working to earn their respect while training them for war. “You already fit in if you’re a male, if you’re a female, it's what is she going to do for me? Kind of attitude. And I was prepared for that," said Larson.But chasing perfection would come at a cost; her own well-being was no longer a priority. As the 12 to 15-hour days and mounting pressure felt out of her control, Larson latched onto what she could control. “The drug was food for me, so it ended up turning into the bulimia end of the first year," said Larson.With rigid fitness standards and weight requirements, the National Eating Disorders Association says service members are at especially high risk for eating disorders.“Abuse of fitness and nutrition tends to be the thing. It might not be full-blown bulimia or anorexia, or anything like that, but it can be a lot of disordered eating. Obviously, with yo-yo dieting, too much exercise or too little exercise can affect your focus," said Larson.Before deploying to Iraq, Larson sought help from a friend but didn’t disclose her illness to the military, fearing she’d lose her job.“I tried to make everyone realize I would be OK because I didn’t want to let the Marines down. You know, mission accomplishment and troop welfare are kind of the things we thrive on as Marines, especially Marine leaders," said Larson. No longer at a desk, leading operations and landmine missions, the responsibility to protect her platoon had never felt greater."It dawned on me, 'gosh, I’m really not OK. And this is not about me. It's about all the Marines I’m taking care of. So yeah, I’m sick, and I’m going to affect someone else.' It was a wake-up call," said Larson.Larson was sent home and said she had to fight to get treatment in the military. While grateful they covered 12 weeks of care in an outpatient rehabilitation clinic, Larson says she was on her own to continue getting help.“Anyone knows that has an addiction, it’s not just a, 'OK, you're done.' It's a continuous, daily decision and practice. And so, I ended up paying for my own care after that for a while," said Larson. "It was a couple of years until I stopped the symptoms of bulimia, and then was just dealing with what was left-- the depression, the anxiety, and managing that.”She says getting healthy became her job. And after the military, Larson helped others do the same. She wrote a memoir about her military experience and has since been contacted by countless service members and veterans struggling with similar challenges. “As a leader, there's a fine line of when you push yourself and when you need to ask for help. And asking for help, I’ve learned, is not a weakness. It’s a strength," said Larson.After earning a doctorate in physical therapy, Larson and her husband founded Movement Rx, a program helping people around the country uncover the root cause of their pain and injuries. “Just because someone is in a wheelchair, that’s not the only thing going on. Or if someone looks like they’re fine, it doesn’t mean they don’t have something going on," said Larson. In addition to free online resources for veterans, Movement Rx has free in-person training for veterans in San Diego. “We have our health care platform that veterans can use, offering mindfulness and meditation, nutrition support, fitness, as well as movement, working through injuries," said Larson. While there's more help now for struggling veterans and service members, Larson knows asking for it is still just as hard. “You asking for help, it's going to open more doors and more growth than you can ever imagine, but you have to take that vulnerable leap, and that's when life really happens." 4633

来源：资阳报